Propranolol hydrochloride Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: 2-Propanol, 1-[(1-methylethyl)amino]-3-(1- naphthalenyloxy)-, hydrochloride, Inderal, Propranolol

Pipeline

Phase 1: 2Phase 2: 1Phase 1/2: 1

Top Sponsors

Weill Medical College of Cornell University1
Washington University School of Medicine1
Second Xiangya Hospital of Central South University1
June Wu1

Indications

Heart Disease2
Cancer2
Tetralogy of Fallot1
Chylothorax1
Open Heart Surgery1

New York, New York2 trials

Beta-blocker Administration for Cardiomyocyte Division

Weill Cornell Medicine

Phase 1

Propranolol Treatment for Postoperative Chylothorax

Columbia University Irving Medical Center/NewYork-Presbyterian

Phase 1/2

Other1 trial

Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer

Phase 1

St Louis, Missouri1 trial

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.